1344684-76-9

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 2735-04-8 2,4-Dimethoxyaniline 
• 260391-75-1 N-(tert-butoxycarbonyl)-2,4-dimethoxyamiline 

Downstream Products

• 1431533-40-2 2-(4-(cyclopropylmethoxy)-3-fluorophenyl)-4-fluoro-1,3-benzoxazol-6-ol 
• 1431533-41-3 tert-butyl ((2S)-1-((2-(4-(cyclopropylmethoxy)-3-fluorophenyl)-4-fluoro-1,3-benzoxazol-6-yl)oxy)propan-2-yl)carbamate 
• 1431531-36-0 N-((2S)-1-((2-(4-(cyclopropylmethoxy)-3-fluorophenyl)-4-fluoro-1,3-benzoxazol-6-yl)oxy)propan-2-yl)acetamide 
• 1431533-38-8 4-(cyclopropylmethoxy)-3-fluoro-N-(2-fluoro-4,6-dihydroxyphenyl)benzamide 

Relevant academic research and scientific papers

BICYCLIC COMPOUND

The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

BICYCLIC COMPOUND

The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer and the like, and has superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification.